-

Realbotix Announces Strategic Partnership with Star Walk Partners

TORONTO--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT | Frankfurt Stock Exchange: 76M | OTC: XBOTF) (“Realbotix” or the “Company”), a leading creator of humanoid robotics and relationship-based AI, has acquired a strategic minority interest in Star Walk Partners LLC.

Star Walk is led by Gary Fuhrman, who has a long and distinguished track record of investing and providing assistance to middle market-branded consumer product and media companies. Gary is also the Chairman and CEO of GF Capital. Current and past investments of GF Capital include Tommy Hilfiger, Warner Music Group, Oscar de la Renta, Blue Man Group, 300 Entertainment, GF Sports, Jonathan Adler, and Airborne. As part of the acquisition, Star Walk will assist Realbotix with its product marketing and sales efforts, including expansion into new verticals.

“Our partnership with Star Walk is a pivotal step in our journey to revolutionize the field of humanoid robotics and AI,” said Andrew Kiguel, CEO of Realbotix. “We are confident that this collaboration will significantly enhance our operational strengths and accelerate our growth trajectory.”

“Next-generation, customizable robots with human-like appearance and movement integrated with AI is a large potential market spanning a number of key verticals including entertainment, healthcare, education, and other market segments” said Gary Fuhrman. “We are excited to work with Realbotix to help the company unlock its numerous growth opportunities.”

As consideration for the acquisition, Realbotix will issue to Star Walk an aggregate of 25 million warrants (the “Warrants”) to purchase common shares in the capital of the Company (the “Common Shares”), such Warrants exercisable at six (6) month intervals in seven (7) tranches (the “Tranches”) over a period of five (5) years, with an exercise price of: (a) US$0.15 per Common Share with respect to the issuance of the first 7,500,000 Warrants; and (b) US$0.20 per Common Share with respect to the issuance of the balance of the Warrants. Each Tranche of Warrants will be exercisable for a 24-month window from the date of their issue, subject to the exercise prices noted above. The exercise of the Warrants may result in Star Walk becoming an insider of the Company.

The Company will own a minority, non-controlling membership interest in Star Walk and has obtained conditional approval from the TSX Venture Exchange in connection with the transaction. Star Walk is an arm’s length party to the Company. No broker, agent or finder’s fee is payable in connection with the transaction.

To learn more about Realbotix, visit www.realbotix.ai.

About Realbotix

Realbotix creates customizable, human-like robots with AI integration that improve the human experience through learning, connection and play. Manufactured in Nevada, USA, we have built a reputation for having the highest quality humanoid robots and the most realistic silicone skin technology on the market.

We operate in a niche part of the massive robotics and AI sectors: Our robots provide companionship to humans. We achieve this through patented technologies that deliver human-like appearance and movements, and our proprietary companionship AI. In addition, our patented silicone skin technology has versatile uses within our robotic products and within healthcare markets such as prosthetics. We have thousands of customers across more than a hundred countries.

Visit Realbotix.AI to learn more.

Keep up-to-date on Realbotix.AI developments and join our online communities on Twitter, LinkedIn, and YouTube.

Forward-Looking Statements

This news release includes certain forward-looking statements as well as management’s objectives, strategies, beliefs and intentions. Forward looking statements are frequently identified by such words as “may”, “will”, “plan”, “expect”, “anticipate”, “estimate”, “intend” and similar words referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management. All forward-looking information is inherently uncertain and subject to a variety of assumptions, risks and uncertainties, including the speculative nature of cryptocurrencies, as described in more detail in our securities filings available at www.sedarplus.ca. Actual events or results may differ materially from those projected in the forward-looking statements and we caution against placing undue reliance thereon. We assume no obligation to revise or update these forward-looking statements except as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts

Realbotix Corp.

Andrew Kiguel, CEO
Email: contact@realbotix.ai

Jennifer Karkula, Head of Communications
Email: contact@realbotix.ai
Telephone: 647-578-7490

Realbotix Corp.

TSX VENTURE:XBOT

Release Versions

Contacts

Realbotix Corp.

Andrew Kiguel, CEO
Email: contact@realbotix.ai

Jennifer Karkula, Head of Communications
Email: contact@realbotix.ai
Telephone: 647-578-7490

More News From Realbotix Corp.

Realbotix Reports Financial Results for Q1-2026

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt Stock Exchange: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading AI software and humanoid robot manufacturer, reports its interim financial results for the three months ended December 31, 2025 (“Q1-2026”). All dollar figures are reported in United States dollars (“USD”), unless otherwise stated. Q1-2025 Financial and Operating Highlights Revenue for Q1 2026 was $353,037, down from $ 815,655 in Q1 2025. This is a...

Realbotix Reports Financial Results for Fiscal Year Ended September 30, 2025

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt Stock Exchange: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leading AI software and humanoid robot manufacturer, reports its audited financial results for the year ended September 30, 2025 (“Q3-2025”). All dollar figures are reported in United States dollars (“USD”), unless otherwise stated. Fiscal Year ended September 2025 Financial and Operating Highlights 121% increase in revenue to $2.0 million from $0.9 million...

Realbotix Provides Financial Reporting Update

LAS VEGAS--(BUSINESS WIRE)--Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (“Realbotix” or the “Company”), a leader in AI-powered humanoid robotics, provides an update on the timing for reporting its financial filings. The Company will file its audited annual financial statements for the year ended September 30, 2025, together with the related management’s discussion and analysis and CEO and CFO certifications (collectively, the “2025 Annual Filings”) on Friday March 6, 2026. Th...
Back to Newsroom